The world is full of extraordinary individuals that come from every walk of life. No matter the skin complexion, these individuals have done some amazing things to better society. Unfortunately, people like this tend to get overlooked even though they’ve brought so much to the table. Society tends to celebrate professional athletes and entertainers on a regular basis. Dr. Clay Siegall just so happens to be one of these extraordinary figures. He has taken a small startup business and have turned it into a worldwide juggernaut. This company is known as Seattle Genetics, and it has revolutionized the medical industry.
Siegall is the chief financial officer, the president and one of the founders of Seattle Genetics. He has studied at the University of Maryland as well as studied at George Washington University. These two higher learning institutions have awarded him with a Ph.D in Genetics as well as a B.S. in Zoology. Siegall specializes in fighting cancer, and he does this via antibody-based therapies. These therapies are actually antibody drug conjugates, and they are some of the best cancer eradicating medications in the history of mankind. They aggressively attack cancer cells without harming any of the good cells. This is innovation at its finest. Being so great, these antibody drug conjugates are now being used in 65 foreign countries. This comes from Siegall’s ability to strike many different licensing deals with high profile companies. The medications are so successful to where they have helped Seattle Genetics grow at a dramatic rate. The company’s stock has tripled in just five short years.
Siegall’s strong passion and determination has turned him into a fan favorite in a sense. This philanthropist has won many philanthropic awards including the Pacific Northwest Ernst & Young Entrepreneur of the Year as well as the 2013 University of Maryland Alumnus of the Year for Computer, Math & Science.